Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
EVIVE Biotechnology
EVIVE Biotechnology
Spectrum Pharmaceuticals, Inc
Spectrum Pharmaceuticals, Inc
Viatris Inc.
EVIVE Biotechnology
Gema Biotech S.A.
Sandoz
Biocad
Sandoz
Jiangsu HengRui Medicine Co., Ltd.
European Organisation for Research and Treatment of Cancer - EORTC
Amgen
National Institutes of Health Clinical Center (CC)